Hey, Ross here:
Here’s your Tuesday edition of this week’s Stock Surge Daily.
Chart of the Day
Catalyst Pharmaceuticals (CPRX) is a biotech stock showing a lot of power.
I found this one in my high growth scan that looks for rapid sales and earnings growth. Not only is the company seeing above-average growth, but the rate is increasing quarter over quarter.
With numbers like these, it’s easy to see why this stock has tripled even in the middle of a treacherous bear market. It also shows why those sitting on the sidelines trying to “wait out” the bear market are only costing themselves – there are still a lot of opportunities out there.
CPRX is forming a pivot near $17.50. If the stock can break out higher on good volume, this is one to consider buying.
Insight of the Day
Don’t blindly accept false choices – always look for options that are not on the table
Check out this chart from Bloomberg showing what various professionals think is the best trade before the Fed makes its decision tomorrow.
Based on this graph, it would seem you only have the choice to either go long on US stocks or go short on them.
This is a prime example of a false choice. If you blindly accept the false choice presented to you, you’ve immediately limited your options – and your profit potential.
For instance, the best trading strategy in this environment is probably to go long on some stocks and short on others, instead of thinking of “US stocks” as a whole. In fact, I KNOW that’s what these professionals working for the Big Money players are doing – because I used to be one of them.
Moral of the story – when presented with “choices”, think carefully about what you haven’t been shown. Oftentimes, that’s where the real opportunities lie. Oh, and if you’re interested in finding out how you could “track” the footsteps of the Big Money and profit right alongside them, click here.
Embrace the surge,
Ross Givens
Editor, Stock Surge Daily
